High Stathmin Expression is a Marker for Poor Clinical Outcome in Endometrial Cancer: an NRG Oncology Group/Gynecologic Oncology Group Study

OBJECTIVE: Gynecologic Oncology Group (GOG) 177 demonstrated that addition of paclitaxel to a backbone of adriamycin/cisplatin improves overall survival (OS) and progression-free survival (PFS) for patients with advanced or recurrent endometrial cancer. Using patient specimens from GOG-177, our obje...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gynecol Oncol
Main Authors: Reyes, Henry D., Miecznikowski, Jeffrey, Gonzalez-Bosquet, Jesus, Devor, Eric J., Zhang, Yuping, Thiel, Kristina W., Samuelson, Megan I., McDonald, Megan, Stephan, Jean-Marie, Hanjani, Parviz, Guntupalli, Saketh, Tewari, Krishnansu S., Backes, Floor, Ramirez, Nilsa, Fleming, Gini F., Filiaci, Virginia, Birrer, Michael J., Leslie, Kimberly K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5526627/
https://ncbi.nlm.nih.gov/pubmed/28532857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2017.05.017
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados